In vitro antimycoplasmal activities of rufloxacin and its metabolite MF 922.

The in vitro activities of rufloxacin and its metabolite, MF 922, were compared with those of ofloxacin, ciprofloxacin, erythromycin, and minocycline against Mycoplasma pneumoniae, Mycoplasma hominis, Mycoplasma fermentans, and Ureaplasma urealyticum. Rufloxacin, MF 922, and ciprofloxacin shared sim...

Fuld beskrivelse

Bibliografiske detaljer

Udgivet i:	Antimicrob Agents Chemother
Principais autores:	Furneri, P M, Bisignano, G, Cerniglia, G, Nicoletti, G, Cesana, M, Tempera, G
Format:	Artigo
Sprog:	Inglês
Udgivet:	American Society for Microbiology (ASM) 1994
Fag:	Research Article
Online adgang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC188257/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7872762/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.11.2651
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!